CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure The association between body mass index and obesity with survival in pulmonary arterial hypertension Prospective Elimination of Distal Coronary Sinus to Left Atrial Connection for Atrial Fibrillation Ablation (PRECAF) Randomized Controlled Trial Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health status Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome

Original Research2011 Feb 1;4(1):9-14.

JOURNAL:Circ Cardiovasc Interv. Article Link

Mechanisms of in-stent restenosis after drug-eluting stent implantation: intravascular ultrasound analysis

Kang SJ, Mintz GS, Park DW et al. Keywords: luminal loss; drug-eluting stent; morphology; in-stent restenosis; restenoisis

FULL TEXT PDF